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Scientific objectives
The Bonn-Risk-Index (BRI) for the determination of the
urinary stone formation risk is based on a crystallization
test induced within a sample of native urine. The estab-
lished method shows superior diagnostic sensitivity and
specificity to other risk indices, derived from the urinary
concentrations of some selected major urinary constitu-
ents considered to be indicators of the urine’s supersatura-
tion with respect to the mineral phase formed by the
patient. However, urinary supersaturation, the major ther-
modynamic driving force for crystal formation, is governed
by all – organic and inorganic – components coexisting in
the solution. In addition to the individual concentration of
the components their mutual interactions also play an
important role. Thus, BRI which “simulates” stone forma-
tion within whole urine meets much better the analytical
demands to describe the “true supersaturation” than the
costly determination of a couple of individual parameters.
Indeed, minor constituents may take higher influence on
an induced crystallisation process as one might expect
from its urinary concentration. Urine composition reflects
the influence of any of the patient’s metabolic processes –
even of those analytically not directly accessible. There-
fore, a change in urine composition leading to a variation
in stone formation risk can indicate a change in the
patient’s general metabolic state. Thus, BRI can also be
used to monitor the general metabolic state by taking into
account all urinary components, even unknown and diffi-
cult to access ones. In particular, changes in the calcium
metabolisms could be detected as BRI is especially devel-
oped for the evaluation of the risk of formation of calcium
stones. Clinical studies that systematically investigate the
BRI, for example, in patients with bone diseases, like
osteoporosis or Paget’s Disease, or in patients with
diseases, which still lack a quantifiable progression para-
meter, should be run.
Outlook
In case of clinically relevant correlations between BRI
and the severity and course of a metabolic disease BRI
can be used to monitor this disease. Therefore, BRI and
the BRI-on-Chip rapid test under development could be
cost-effective diagnostic tools for many other metabolic
diseases than urolithiasis, too.
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